Train Babcock Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,438
Closed -$210K 115
2017
Q3
$210K Buy
+1,438
New +$196K 0.12% 83
2017
Q2
Sell
-1,648
Closed -$205K 115
2017
Q1
$205K Buy
+1,648
New +$197K 0.09% 110
2016
Q1
Sell
-1,953
Closed -$234K 122
2015
Q4
$234K Sell
1,953
-355
-15% -$41.1K 0.09% 112
2015
Q3
$250K Hold
2,308
0.09% 112
2015
Q2
$267K Sell
2,308
-85
-4% -$9.72K 0.08% 117
2015
Q1
$276K Sell
2,393
-10
-0.4% -$1.2K 0.09% 115
2014
Q4
$269K Sell
2,403
-22
-0.9% -$2.32K 0.09% 110
2014
Q3
$230K Buy
+2,425
New +$219K 0.08% 113

Other funds holding CELG

Train Babcock Advisors's CELG Position: Q4 2017 in Review

Train Babcock Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,438 shares — an estimated $210K sold.

Train Babcock Advisors first reported a position in CELG in Q3 2014 and held it in 8 quarters. The position peaked at $276K in Q1 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Train Babcock Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Train Babcock Advisors sold 1,438 Celgene Corp shares in Q4 2017, an estimated $210K.
  • Train Babcock Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 8 quarters.
  • Train Babcock Advisors's Celgene Corp position peaked at $276K in Q1 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.